HNRNPK and prostate carcinoma: Overall, these results suggest that hnRNP K in prostate cancer cell lines is likely to act as an AR transcriptional collaborator that regulates AR activity through different molecular mechanisms depending on cell differentiation, supporting the hypothesis of the involvement of hnRNP K in ADT resistance.